Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.

Hyderabad, India, July 1, 2015: Asia's leading Discovery Research and Development organization, GVK BIO, announced the extended collaboration with Melbourne, Australia based clinical stage ...

Scientists have successfully tested the use of machine learning models to guide the design of long-acting injectable drug formulations. The potential for machine learning algorithms to accelerate drug ...

PharmTech spoke with Dr. Asma Patel, VP Global Commercial and Scientific Consulting–Drug Product, to find out how the growth ...

CRDMOs offer a continuum of services from early discovery to clinical manufacturing, addressing solubility and stability challenges in NCE development. Advanced technologies like spray drying and ...

Solubility is fundamental in successfully developing all classes of therapeutic biopolymers. Contact with stressors related to mechanical stirring or changes in buffer conditions may cause ...

A biotech company based in Spain says that new formulations are allowing the organization to deliver larger molecules straight to the pulmonary system. RidNova Pharmaceuticals says it’s using ...

Clinical evaluation of several modified release once-daily formulations of danuglipron resulted in encouraging pharmacokinetic data for several candidates with one showing the most favorable profile ...

Ofichem Group, a company specialized in formulation development based in Nijmegen, the Netherlands, has signed a definitive agreement to acquire Avivia BV. The acquisition marks a significant step in ...

ALBANY, N.Y.--(BUSINESS WIRE)--Curia, formerly AMRI, a leading contract research, development and manufacturing organization, today announced it has entered into a definitive agreement to acquire ...